Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
18
|
| pubmed:dateCreated |
1998-2-25
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
1043-0342
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
10
|
| pubmed:volume |
8
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2170-2
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9449370-Antigens, CD34,
pubmed-meshheading:9449370-Gene Therapy,
pubmed-meshheading:9449370-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:9449370-HIV Infections,
pubmed-meshheading:9449370-Hematopoietic Stem Cells,
pubmed-meshheading:9449370-Humans,
pubmed-meshheading:9449370-RNA, Catalytic
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
The use of peripheral blood hematopoietic progenitors for human immunodeficiency virus gene therapy.
|
| pubmed:publicationType |
Journal Article,
Comment
|